Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review

Asahi Kasei Corp (3407) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Asahi Kasei Corp (Asahi Kasei) manufactures and markets chemical products. The product portfolio of the company includes polymers, acrylonitrile, styrene, diagnostic reagents, foam insulation panels, foundation systems, methyl methacrylate, polyethylene, polystyrene, functional additives, membrane filtration systems, ion-exchange membranes, medical devices and sensors. Its products find application in the fields of chemicals and fibers, electronics, healthcare and construction. It markets its products under Duranol, Sepacell, Polydurex, Ceolus, Aciplex and Hipore brands. The company has operational presence in North America, Central and South America, Europe, Asia and Oceania. Asahi Kasei is headquartered in Chiyoda-ku, Tokyo, Japan.

Asahi Kasei Corp Key Recent Developments

Apr 03,2020: Asahi Kasei’s electrolysis system starts world’s largest-scale hydrogen supply operation at the Fukushima Hydrogen Energy Research Field in Namie
Jan 17,2020: Restart schedule of naphtha cracker of Asahi Kasei Mitsubishi Chemical Ethylene
Nov 26,2019: Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 


Section 1 - About the Company
Asahi Kasei Corp - Key Facts
Asahi Kasei Corp - Key Employees
Asahi Kasei Corp - Major Products and Services
Asahi Kasei Corp - History
Asahi Kasei Corp - Company Statement
Asahi Kasei Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Asahi Kasei Corp - Business Description
Business Segment: Health Care
Overview
Performance
Business Segment: Homes
Overview
Performance
Business Segment: Material
Overview
Performance
Geographical Segment: China
Performance
Geographical Segment: Japan
Performance
Geographical Segment: Other Regions
Performance
Geographical Segment: The US
Performance
Asahi Kasei Corp - SWOT Analysis
SWOT Analysis - Overview
Asahi Kasei Corp - Strengths
Asahi Kasei Corp - Weaknesses
Asahi Kasei Corp - Opportunities
Asahi Kasei Corp - Threats
Asahi Kasei Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Asahi Kasei Corp, Petrochemicals, Deals By Year, 2014 to YTD 2020
Asahi Kasei Corp, Petrochemicals, Deals By Type, 2014 to YTD 2020
Asahi Kasei Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 03, 2020: Asahi Kasei’s electrolysis system starts world’s largest-scale hydrogen supply operation at the Fukushima Hydrogen Energy Research Field in Namie
Jan 17, 2020: Restart schedule of naphtha cracker of Asahi Kasei Mitsubishi Chemical Ethylene
Nov 26, 2019: Asahi Kasei offers to buy Veloxis Pharmaceuticals for $1.3bn
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 


List Of Tables

 
Asahi Kasei Corp, Key Facts
Asahi Kasei Corp, Key Employees
Asahi Kasei Corp, Major Products and Services
Asahi Kasei Corp, History
Asahi Kasei Corp, Subsidiaries
Asahi Kasei Corp, Joint Venture
Asahi Kasei Corp, Key Competitors
Asahi Kasei Corp, Ratios based on current share price
Asahi Kasei Corp, Annual Ratios
Asahi Kasei Corp, Annual Ratios (Cont...1)
Asahi Kasei Corp, Annual Ratios (Cont...2)
Asahi Kasei Corp, Interim Ratios
Asahi Kasei Corp, Petrochemicals, Deals By Year, 2014 to YTD 2020
Asahi Kasei Corp, Petrochemicals, Deals By Type, 2014 to YTD 2020
Asahi Kasei Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 


List Of Figures

 
Asahi Kasei Corp, Performance Chart (2016 - 2020)
Asahi Kasei Corp, Ratio Charts
Asahi Kasei Corp, Petrochemicals, Deals By Year, 2014 to YTD 2020
Asahi Kasei Corp, Petrochemicals, Deals by Type, 2014 to YTD 2020
 


TV Asahi Corporation (9409) - Financial and Strategic SWOT Analysis Review

TV Asahi Corporation (9409) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled to

USD 125 View Report

Asahi Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report

Asahi Group Holdings, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the companys structure, operation, SWOT analysis, product

USD 175 View Report

Asahi Kasei Pharma Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile.

Asahi Kasei Pharma Corp (Asahi Kasei Pharma), a subsidiary of Asahi Kasei Corp, discovers, develops, manufactures, and markets pharmaceuticals and diagnostic products. The companys portfolio encompasses prescription drugs, diagnostic reagents,

USD 250 View Report

Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review

Asahi Kasei Pharma Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis,

USD 125 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available